- Title
- Human immunodeficiency virus type 1 pharmacogenomics in clinical practice: Relevance of HIV-1 Drug resistance testing (Part 2)
- Creators
- Roberto PATARCA - E.M. Papper Laboratory of Clinical Immunology and Molecular Biology, University of Miami School of Medicine, Miami, Florida, 2, United StatesAlejandro ISAVA - Department of Pediatrics, Jackson Memorial Hospital, Miami, Florida, United StatesGwendolyn SCOTT - Department of Pediatrics, Jackson Memorial Hospital, Miami, Florida, United StatesDushyantha JAYAWEERA - Department of Internal Medicine, Jackson Memorial Hospital, Miami, Florida, United StatesJose MORENO - Department of Internal Medicine, Jackson Memorial Hospital, Miami, Florida, United StatesCatherine BOULANGER - Department of Internal Medicine, Jackson Memorial Hospital, Miami, Florida, United StatesMichael KOLBER - Department of Internal Medicine, Jackson Memorial Hospital, Miami, Florida, United StatesCindy W MASK - Visible Genetics, Inc., Suwanee, Georgia, United StatesEduardo Meneses SIERRA - Hospital Christus Muguerza, Saltillo, Coahuila CP, MexicoRicardo VALLEJO - Department of Anesthesiology, Massachusetts General Hospital, Boston, Massachusetts, United StatesJ. Brian PAGE - E.M. Papper Laboratory of Clinical Immunology and Molecular Biology, University of Miami School of Medicine, Miami, Florida, 2, United StatesNancy G KLIMAS - E.M. Papper Laboratory of Clinical Immunology and Molecular Biology, University of Miami School of Medicine, Miami, Florida, 2, United StatesRafael CAMPO - Department of Internal Medicine, Jackson Memorial Hospital, Miami, Florida, United StatesMary Ann FLETCHER - E.M. Papper Laboratory of Clinical Immunology and Molecular Biology, University of Miami School of Medicine, Miami, Florida, 2, United StatesNelson J RODRIGUEZ - E.M. Papper Laboratory of Clinical Immunology and Molecular Biology, University of Miami School of Medicine, Miami, Florida, 2, United StatesEnriqueta NUNEZ - E.M. Papper Laboratory of Clinical Immunology and Molecular Biology, University of Miami School of Medicine, Miami, Florida, 2, United StatesMichael ALTER - E.M. Papper Laboratory of Clinical Immunology and Molecular Biology, University of Miami School of Medicine, Miami, Florida, 2, United StatesMargaret MARCHETTE - E.M. Papper Laboratory of Clinical Immunology and Molecular Biology, University of Miami School of Medicine, Miami, Florida, 2, United StatesMirtha M SANABIA - E.M. Papper Laboratory of Clinical Immunology and Molecular Biology, University of Miami School of Medicine, Miami, Florida, 2, United StatesCharles MITCHELL - Department of Pediatrics, Jackson Memorial Hospital, Miami, Florida, United StatesDelia RIVERA - Department of Pediatrics, Jackson Memorial Hospital, Miami, Florida, United States
- Publication Details
- Journal of environmental pathology, toxicology and oncology, Vol.22(4), pp.235-279
- Publisher
- Begell House; Wallingford; New York, NY
- Academic Unit
- Miller School of Medicine; College of A&S; UMMG Department of Pediatrics; UMMG Dept of Medicine - Infectious Diseases; UMMG Dept of Pediatrics - Infectious Diseases; A&S - Anthropology
- Language
- English
- Resource Type
- Journal article
- PMID
- 14669906
- Record Identifier
- 991031559005302976
Journal article
Human immunodeficiency virus type 1 pharmacogenomics in clinical practice: Relevance of HIV-1 Drug resistance testing (Part 2)
Journal of environmental pathology, toxicology and oncology, Vol.22(4), pp.235-279
2003
PMID: 14669906
Metrics
18 Record Views